Publicaciones en colaboración con investigadores/as de Centers for Disease Control and Prevention (21)

2020

  1. The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV

    Journal of the International AIDS Society

2019

  1. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature

2018

  1. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1

2016

  1. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis

    Influenza and other Respiratory Viruses, Vol. 10, Núm. 3, pp. 192-204

2015

  1. Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 11, pp. 6725-6732

2014

  1. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data

    The Lancet Respiratory Medicine, Vol. 2, Núm. 5, pp. 395-404

2013

  1. Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study

    PLoS Medicine, Vol. 10, Núm. 11

2012

  1. Lipid-related markers and cardiovascular disease prediction

    JAMA - Journal of the American Medical Association, Vol. 307, Núm. 23, pp. 2499-2506

2009

  1. Major lipids, apolipoproteins, and risk of vascular disease

    JAMA, Vol. 302, Núm. 18, pp. 1993-2000

2006

  1. Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda

    Annals of Tropical Paediatrics, Vol. 26, Núm. 3, pp. 169-179

2005

  1. Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction

    Journal of Clinical Investigation, Vol. 115, Núm. 2, pp. 379-387

2004

  1. Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies

    Journal of Biological Chemistry, Vol. 279, Núm. 24, pp. 25838-25848

  2. Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activity

    Structure, Vol. 12, Núm. 10, pp. 1799-1807

2001

  1. Duration of ruptured membranes and vertical transmission of HIV-1: A meta-analysis from 15 prospective cohort studies

    AIDS, Vol. 15, Núm. 3, pp. 357-368

1999

  1. Epidemiologic evidence for a new class of compounds associated with toxic oil syndrome

    Epidemiology, Vol. 10, Núm. 2, pp. 130-134

1998

  1. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins

    Science, Vol. 279, Núm. 5353, pp. 1034-1037

  2. Toxic oil syndrome mortality: The first 13 years

    International Journal of Epidemiology, Vol. 27, Núm. 6, pp. 1057-1063

1997

  1. Epidemiology of the toxic oil syndrome.

    Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement, Vol. 19, pp. 41-52

  2. Microsporidiosis in HIV-positive children in madrid (Spain)

    Journal of Eukaryotic Microbiology

1996

  1. Toxic oil syndrome: Traceback of the toxic oil and evidence for a point source epidemic

    Food and Chemical Toxicology, Vol. 34, Núm. 3, pp. 251-257